One month after Hong Kong Exchanges and Clearing (HKEX) proposed its major listing reforms—the biggest since 2018—a leading law firm says the changes will make the city more attractive to smaller AI and biotech companies previously priced out of weighted voting rights (WVR) listings. HKEX's 'listing reform 2.0' halves the WVR market cap threshold to HK$20 billion and allows confidential filings for all issuers. Consultation ends May 8.
Hong Kong Exchanges and Clearing (HKEX) proposed sweeping listing changes last month, including halving the minimum market cap for weighted voting rights (WVR) companies to HK$20 billion (US$2.6 billion) from HK$40 billion, easing paths for overseas issuers, and permitting confidential filings for all companies.
Clifford Chance, which has advised over a dozen innovative firms on fundraising under the 2018 regime, sees the reforms as a game-changer. Partner Fang noted: “The current market cap requirement for WVR [firms] is out of reach for the substantial majority of potential listing candidates.” His team assisted 14 companies with IPOs in Q1 alone, raising US$5.7 billion.
“The HKEX proposal to lower the market cap requirement will enhance the attractiveness of Hong Kong, as many of the relatively smaller innovative companies now have the option to list here [under the WVR framework],” Fang added.
The reforms build on 2018 changes that enabled listings like Xiaomi and Meituan, aiming to position Hong Kong as a hub for AI, biotech, and growth firms amid shifting investor interest in Asia.
